In vitro evaluation of anthelmintic activity of biocompatibile carbon quantum dot nanocomposite against egg and larval stages of equine strongyles
Abstract
BACKGROUND: Strongyle nematodes pose a major challenge in veterinary parasitology, causing significant economic losses in livestock due to resistance to conventional treatments. Current anthelmintics, like Ivermectin, often encounter resistance issues. This study aims to address these gaps by synthesizing Carbon Quantum Dots (CQDs) and Copper-Doped CQDs (Cu@CQDs) using glucose extract, and evaluating their nematicidal properties against strongyles in vitro. We assessed the nematicidal effects of CQDs and Cu@CQDs through larval feeding inhibition of first-stage larvae (L1), egg hatch inhibition (EHI), and the mobility and mortality of infectious larvae (L3s). Additionally, we conducted ultrastructural examinations of eggs and larvae and evaluated oxidative/nitrosative stress indicators, including total antioxidant status (TAS), protein carbonylation (PCO), lipid peroxidation (MDA), and oxidative DNA damage in homogenized samples of L3s. RESULTS: The synthesized CQDs displayed semi-spherical morphology with diameters under 30 nm. Cu@CQDs at 12.5 µg/ml achieved over 90% EHI and larval motility inhibition. Fluorescence microscopy confirmed over 90% larval feeding inhibition at the same concentration. Both CQDs and Cu@CQDs induced oxidative stress, indicated by decreased TAS and increased MDA, PCO, and oxidative DNA damage. Scanning Electron Microscopy showed that CQDs and Cu@CQDs penetrated the larvae cuticle, altered the tegument, caused larval mortality, and resulted in egg…
Read the paper
Related studies
- Chaos and quantum thermalization
- The Dalton quantum chemistry program system
- Cord Blood Leptin and Adiponectin as Predictors of Adiposity in Children at 3 Years of Age: A Prospective Cohort Study
- Quantitative metabolomics by H-NMR and LC-MS/MS confirms altered metabolic pathways in diabetes
- Stable adiabatic quantum batteries
- A novel self-lipid antigen targets human T cells against CD1c(+) leukemias
Go deeper in Evidence Hub
Evidence Hub adds a study data sheet (design, sample size, evidence level, key numbers), an AI summary and a chat grounded in the paper's text.